OVERVIEW

Cancer Summaries and Commentaries™: Update from Barcelona: Advances in the Treatment of Gastrointestinal (GI) Cancers: Cholangiocarcinoma and Pancreatic Cancer is organized by Physicians' Education Resource, LLC (PER).

Release Date: December 20, 2019
Expiration Date: December 20, 2020

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
This online activity is designed to update clinicians on data presented at the European Society for Medical Oncology Congress 2019 (ESMO 2019), held September 27 to October 1, 2019, in Barcelona, Spain. This Cancer Summaries and Commentaries™ continuing medical education (CME) activity facilitates critical assessment and clinical integration of new evidence, when appropriate. The activity reviews 4 abstracts from ESMO 2019 that focus on cholangiocarcinoma and pancreatic cancer. For each abstract, a text summary of key clinical data is accompanied by perspectives from expert thought leaders who provide insights into how clinicians can apply these findings to their clinical practice to improve patient care.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Outline methods that allow for optimized characterization of tumor biology among patients with GI cancers
• Explain the study design, rationale, and results of recent clinical trials evaluating novel strategies for the treatment of GI cancers
• Consider recent evidence in the context of evolving treatment paradigms in the field of GI cancers